Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM)
India · Delayed Price · Currency is INR 269.25
-9.10 (-3.27%)
Aug 6, 2025, 3:29 PM IST
Blueprint Medicines Market Cap
Jagsonpal Pharmaceuticals has a market cap or net worth of 17.92 billion as of August 6, 2025. Its market cap has increased by 97.47% in one year.
Market Cap
17.92B
Enterprise Value
16.73B
Revenue
2.83B
Ranking
n/a
PE Ratio
29.71
Stock Price
$269.25
Market Cap Chart
Since March 1, 2000, Jagsonpal Pharmaceuticals's market cap has increased from 17.63B to 17.92B, an increase of 1.65%. That is a compound annual growth rate of 0.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2025 | 17.92B | 10.53% |
| Dec 31, 2024 | 16.22B | 58.61% |
| Dec 29, 2023 | 10.22B | 4.69% |
| Dec 30, 2022 | 9.77B | 108.36% |
| Dec 31, 2021 | 4.69B | 150.03% |
| Dec 31, 2020 | 1.87B | 178.40% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,915.95B |
| Divi's Laboratories | 1,722.76B |
| Cipla | 1,211.47B |
| Mankind Pharma | 1,080.90B |
| Apollo Hospitals Enterprise | 1,050.78B |
| Zydus Lifesciences | 966.24B |
| Fortis Healthcare | 650.70B |
| Aurobindo Pharma | 633.31B |